PDS Biotechnology (PDSB) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) reported Q2 EPS of ($0.20), $0.08 better than the analyst estimate of ($0.28).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Ideal Power (IPWR) Tops Q2 EPS by 2c
- Exclusive: BitGo says institutional conversations are shifting to tokenization
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
